This inventor holds 2 USPTO granted patents. Top assignees: Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts, Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2008.
Company Filing History:
1 out of 20 
1 out of 166 
Years Active: 2008
Title: Innovations in Vaccination: The Contributions of Kai Pohlmeyer
Introduction
Kai Pohlmeyer is a notable inventor based in Munich, Germany. He has made significant contributions to the field of vaccine development, particularly in relation to diseases caused by papilloma viruses. With a total of 2 patents, his work is paving the way for advancements in polyvalent vaccines.
Latest Patents
Pohlmeyer's latest patents focus on the production and applications of polyvalent vaccines against diseases caused by papilloma viruses. The patents describe a vaccine that includes methods for creating expression vectors containing the DNA code for structural proteins of papilloma viruses. These vectors are injected into mammals, leading to the generation of serums that are tested for antibodies against various papilloma virus types. The process involves identifying structural protein gene clones that code for a polyvalent vaccine, which is then produced for vaccination purposes.
Career Highlights
Throughout his career, Pohlmeyer has worked with esteemed organizations such as the German Cancer Research Center (Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts). His research has been instrumental in advancing the understanding and treatment of diseases related to papilloma viruses.
Collaborations
Pohlmeyer has collaborated with notable colleagues, including Lutz Gissmann and Martin Müller. These partnerships have contributed to the success of his research and innovations in vaccine development.
Conclusion
Kai Pohlmeyer's work in the field of vaccine development represents a significant advancement in combating diseases caused by papilloma viruses. His innovative approaches and collaborations continue to influence the future of medical research and public health.